TickerFacts.

Galectin Therapeutics Inc (GALT): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2013-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$0
Year ended 2024-12-31
$12.0K2010-12-31: $12.0K2011-12-31: $9.0K2012-12-31: $3.0K2013-12-31: $3.0K2014-12-31: $2.0K2015-12-31: $1.0K2016-12-31: $02017-12-31: $02018-12-31: $02019-12-31: $02020-12-31: $02021-12-31: $02022-12-31: $02023-12-31: $02024-12-31: $0$0
2010-12-31 Depreciation & Amortization (USD) 2024-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2024-12-31$0n/a2025-03-31, From 2024-01-01
2023-12-31$0n/a2025-03-31, From 2023-01-01
2022-12-31$0n/a2024-03-29, From 2022-01-01
2021-12-31$0n/a2023-03-30, From 2021-01-01
2020-12-31$0n/a2022-03-31, From 2020-01-01
2019-12-31$0n/a2021-03-31, From 2019-01-01
2018-12-31$0n/a2020-03-16, From 2018-01-01
2017-12-31$0n/a2019-03-06, From 2017-01-01
2016-12-31$0-100.0%2018-03-29, From 2016-01-01
2015-12-31$1.0K-50.0%2017-03-28, From 2015-01-01
2014-12-31$2.0K-33.3%2016-03-15, From 2014-01-01
2013-12-31$3.0Kn/c2016-03-15, From 2013-01-01
2012-12-31$3.0K-66.7%2014-03-21, From 2012-01-01
2011-12-31$9.0K-25.0%2013-03-29, From 2011-01-01
2010-12-31$12.0Kn/a2012-03-30, From 2010-01-01